AR signaling is crucial for the development of PCa, and reactivation of the AR signaling pathway in BMPC is one of the main mechanisms contributing to acquired resistance to AR‐targeted therapies.[29, 30] Thus, we investigated whether ECM1 could reactivate the AR signaling pathway in tumor cells even in the presence of ENZ. The gene discussed is AR; the disease is neoplasm.